Christine Dingivan

Christine Dingivan is an accomplished leader in the biopharmaceutical and clinical research sectors, currently serving as a Corporate Advisory Board Member at Medable, Inc. and MEDGENOME, while previously holding the role of President and CEO at Emmes. With a strong background at Novartis, Dingivan was the first global head of data and digital, implementing innovative strategies to enhance drug development processes. A former Chief Medical Officer at PPD, Dingivan also held key positions at MedImmune, where a successful career spanned over a decade. Dingivan holds an M.D. from the Geisel School of Medicine at Dartmouth, along with a B.Eng. in Bioengineering and Biomedical Engineering from the University of Pennsylvania.